Money is often a leading source of conflict for couples due to a fear of financial communication. That is why John Hancock is out with a new app to help ease the communication and planning around saving and spending money.
Steve Dorval is the head of innovation at John Hancock. He joins Cheddar to talk about their new app and why couples have such a hard time with finances.
Dorval explains that many individuals are fearful to save and talk about money on their own, so when it comes to doing so with a partner, they often have even greater difficulty. John Hancock wanted to create an app that simplified this process.
Dorval shares some saving hacks. He says couples should pick something and then just get started. Pick a goal that you are emotionally invested in. A lot of couples get started by saving for a mortgage or their dream vacation.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
